Literature DB >> 3486292

Inhibitors of dihydropteroate synthase: substituent effects in the side-chain aromatic ring of 6-[[3-(aryloxy)propyl]amino]-5-nitrosoisocytosines and synthesis and inhibitory potency of bridged 5-nitrosoisocytosine-p-aminobenzoic acid analogues.

O W Lever, L N Bell, C Hyman, H M McGuire, R Ferone.   

Abstract

We previously reported that 6-(methylamino)-5-nitrosoisocytosine (5) is a potent inhibitor (I50 = 1.6 microM) of Escherichia coli dihydropteroate synthase. It was noted that 6-amino substituents larger than methyl were detrimental to binding, although the adverse steric effect could be overcome by a positive ancillary binding contribution of a phenyl ring attached at the terminus of certain 6-alkylamino substituents. We selected the 6-[[3-(aryloxy)propyl]amino]-5-nitrosoisocytosine structure as a parent system and explored the effects of aromatic substituents on synthase inhibition. The nature of the aryl substitution influences binding, as shown by a 30-fold range of inhibitory potencies observed for the 15 aryl analogues (I50 values = 0.6-18 microM), although there is no apparent correlation between synthase inhibition and the electronic or hydrophobic characteristics of the aryl substituents. To explore the possibility that the aryl ring of these inhibitors might interact with the synthase binding site for the substrate p-aminobenzoic acid (PABA), three compounds were synthesized in which a PABA analogue is bridged to the nitrosoisocytosine moiety by linkage to an amino group at C-6 of the isocytosine. The bridged analogues significantly inhibited the synthase (I50 values = 2.5-8.9 microM) but were of unexceptional potency compared with other members of the (aryloxy)propyl series. Structure-activity considerations and inhibition kinetics did not support the PABA binding site as the synthase region that interacts with the aryl ring of these inhibitors. Despite the potent synthase inhibition exhibited by many of the nitrosoisocytosines studied, none of the 18 new analogues showed significant antibacterial activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486292     DOI: 10.1021/jm00155a014

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

Review 1.  Comparative folate metabolism in humans and malaria parasites (part II): activities as yet untargeted or specific to Plasmodium.

Authors:  Alexis Nzila; Steve A Ward; Kevin Marsh; Paul F G Sims; John E Hyde
Journal:  Trends Parasitol       Date:  2005-07

2.  Development of a pterin-based fluorescent probe for screening dihydropteroate synthase.

Authors:  Ying Zhao; Dalia Hammoudeh; Wenwei Lin; Sourav Das; Mi-Kyung Yun; Zhenmei Li; Elizabeth Griffith; Taosheng Chen; Stephen W White; Richard E Lee
Journal:  Bioconjug Chem       Date:  2011-09-30       Impact factor: 4.774

Review 3.  Replacing sulfa drugs with novel DHPS inhibitors.

Authors:  Dalia I Hammoudeh; Ying Zhao; Stephen W White; Richard E Lee
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

Review 4.  Targeting purine and pyrimidine metabolism in human apicomplexan parasites.

Authors:  John E Hyde
Journal:  Curr Drug Targets       Date:  2007-01       Impact factor: 3.465

5.  Crystal structure of Arabidopsis thaliana HPPK/DHPS, a bifunctional enzyme and target of the herbicide asulam.

Authors:  Grishma Vadlamani; Kirill V Sukhoverkov; Joel Haywood; Karen J Breese; Mark F Fisher; Keith A Stubbs; Charles S Bond; Joshua S Mylne
Journal:  Plant Commun       Date:  2022-04-09

6.  Structural studies of pterin-based inhibitors of dihydropteroate synthase.

Authors:  Kirk E Hevener; Mi-Kyung Yun; Jianjun Qi; Iain D Kerr; Kerim Babaoglu; Julian G Hurdle; Kanya Balakrishna; Stephen W White; Richard E Lee
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

7.  Validation of molecular docking programs for virtual screening against dihydropteroate synthase.

Authors:  Kirk E Hevener; Wei Zhao; David M Ball; Kerim Babaoglu; Jianjun Qi; Stephen W White; Richard E Lee
Journal:  J Chem Inf Model       Date:  2009-02       Impact factor: 4.956

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.